JP2025090679A5 - - Google Patents
Info
- Publication number
- JP2025090679A5 JP2025090679A5 JP2025036066A JP2025036066A JP2025090679A5 JP 2025090679 A5 JP2025090679 A5 JP 2025090679A5 JP 2025036066 A JP2025036066 A JP 2025036066A JP 2025036066 A JP2025036066 A JP 2025036066A JP 2025090679 A5 JP2025090679 A5 JP 2025090679A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- seq
- amino acid
- antibody
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962800869P | 2019-02-04 | 2019-02-04 | |
| US62/800,869 | 2019-02-04 | ||
| JP2021545713A JP7709917B2 (ja) | 2019-02-04 | 2020-02-04 | コネキシン４３抗体およびその使用 |
| PCT/US2020/016606 WO2020163353A1 (en) | 2019-02-04 | 2020-02-04 | Connexin 43 antibodies and use thereof |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021545713A Division JP7709917B2 (ja) | 2019-02-04 | 2020-02-04 | コネキシン４３抗体およびその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025090679A JP2025090679A (ja) | 2025-06-17 |
| JP2025090679A5 true JP2025090679A5 (enExample) | 2025-08-21 |
Family
ID=71947290
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021545713A Active JP7709917B2 (ja) | 2019-02-04 | 2020-02-04 | コネキシン４３抗体およびその使用 |
| JP2025036066A Pending JP2025090679A (ja) | 2019-02-04 | 2025-03-07 | コネキシン４３抗体およびその使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021545713A Active JP7709917B2 (ja) | 2019-02-04 | 2020-02-04 | コネキシン４３抗体およびその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US12187794B2 (enExample) |
| EP (1) | EP3920969A4 (enExample) |
| JP (2) | JP7709917B2 (enExample) |
| KR (1) | KR20210153039A (enExample) |
| CN (2) | CN119700967A (enExample) |
| AU (2) | AU2020219112A1 (enExample) |
| CA (1) | CA3128987A1 (enExample) |
| IL (2) | IL285369B2 (enExample) |
| WO (1) | WO2020163353A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2019249427A1 (en) | 2018-04-02 | 2020-10-29 | Alamab Therapeutics, Inc. | Connexin 43 antibodies and use thereof |
| WO2022026914A1 (en) * | 2020-07-31 | 2022-02-03 | Alamab Therapeutics, Inc. | Anti-connexin antibody formulations |
| WO2025006774A1 (en) * | 2023-06-30 | 2025-01-02 | Alamab Therapeutics, Inc. | Method of treating osteoarthritis |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4399216A (en) | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4740461A (en) | 1983-12-27 | 1988-04-26 | Genetics Institute, Inc. | Vectors and methods for transformation of eucaryotic cells |
| US4959455A (en) | 1986-07-14 | 1990-09-25 | Genetics Institute, Inc. | Primate hematopoietic growth factors IL-3 and pharmaceutical compositions |
| US4912040A (en) | 1986-11-14 | 1990-03-27 | Genetics Institute, Inc. | Eucaryotic expression system |
| GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| DE69133566T2 (de) | 1990-01-12 | 2007-12-06 | Amgen Fremont Inc. | Bildung von xenogenen Antikörpern |
| KR100272077B1 (ko) | 1990-08-29 | 2000-11-15 | 젠팜인터내셔날,인코포레이티드 | 이종 항체를 생산할 수 있는 전이유전자를 가진 인간이외의 동물 |
| WO1994002602A1 (en) | 1992-07-24 | 1994-02-03 | Cell Genesys, Inc. | Generation of xenogeneic antibodies |
| JP4312259B2 (ja) | 1995-04-27 | 2009-08-12 | アムジェン フレモント インク． | 免疫したゼノマウス（ＸｅｎｏＭｏｕｓｅ）に由来するヒト抗体 |
| US6342220B1 (en) | 1997-08-25 | 2002-01-29 | Genentech, Inc. | Agonist antibodies |
| WO2003057881A1 (en) * | 2001-12-28 | 2003-07-17 | Chugai Seiyaku Kabushiki Kaisha | Method of stabilizing protein |
| US6745478B2 (en) | 2002-07-18 | 2004-06-08 | Delillo Dominick D. | Multi-purpose work knife |
| DK1711207T3 (da) | 2003-12-10 | 2013-03-11 | Medarex Inc | Interferon-alpha-antistoffer og anvendelse heraf |
| CA2596412A1 (en) | 2005-02-03 | 2006-12-21 | Coda Therapeutics Limited | Anti-connexin compounds and uses thereof |
| BRPI0912198A2 (pt) * | 2008-05-15 | 2019-09-24 | Biogen Idec Inc | anticorpos anti-fn14 e usos dos mesmos |
| JP2011524345A (ja) | 2008-06-04 | 2011-09-01 | コーダ セラピューティクス， インコーポレイテッド | ギャップジャンクション調節化合物を用いる疼痛の治療 |
| JP5886212B2 (ja) | 2010-12-27 | 2016-03-16 | Ｌｓｉｐファンド運営合同会社 | ｉＰＳ細胞とその製造法 |
| EP3036005A4 (en) * | 2013-08-21 | 2017-04-26 | The Board Of Regents Of The University Of Texas System | Compositions and methods for targeting connexin hemichannels |
| US9493552B2 (en) | 2013-11-15 | 2016-11-15 | China Synthetic Rubber Corporation | Therapeutic biologic for treatment of hepatocellular carcinoma |
| JP6683686B2 (ja) * | 2014-08-22 | 2020-04-22 | オークランド ユニサービシーズ リミティド | チャネル調節剤 |
| WO2017024465A1 (en) * | 2015-08-10 | 2017-02-16 | Innovent Biologics (Suzhou) Co., Ltd. | Pd-1 antibodies |
| WO2017147561A1 (en) | 2016-02-26 | 2017-08-31 | The Board Of Regents Of The University Of Texas System | CONNEXIN (Cx) 43 HEMICHANNEL-BINDING ANTIBODIES AND USES THEREOF |
| AU2019249427A1 (en) | 2018-04-02 | 2020-10-29 | Alamab Therapeutics, Inc. | Connexin 43 antibodies and use thereof |
| WO2022026914A1 (en) * | 2020-07-31 | 2022-02-03 | Alamab Therapeutics, Inc. | Anti-connexin antibody formulations |
-
2020
- 2020-02-04 US US17/767,171 patent/US12187794B2/en active Active
- 2020-02-04 KR KR1020217027864A patent/KR20210153039A/ko active Pending
- 2020-02-04 EP EP20752507.2A patent/EP3920969A4/en active Pending
- 2020-02-04 AU AU2020219112A patent/AU2020219112A1/en not_active Abandoned
- 2020-02-04 CN CN202411949862.9A patent/CN119700967A/zh active Pending
- 2020-02-04 WO PCT/US2020/016606 patent/WO2020163353A1/en not_active Ceased
- 2020-02-04 CA CA3128987A patent/CA3128987A1/en active Pending
- 2020-02-04 JP JP2021545713A patent/JP7709917B2/ja active Active
- 2020-02-04 CN CN202080002561.9A patent/CN112384244B/zh active Active
- 2020-02-04 IL IL285369A patent/IL285369B2/en unknown
- 2020-02-04 IL IL320816A patent/IL320816A/en unknown
-
2022
- 2022-08-18 AU AU2022218583A patent/AU2022218583B9/en active Active
-
2024
- 2024-11-21 US US18/955,222 patent/US20250230233A1/en active Pending
-
2025
- 2025-03-07 JP JP2025036066A patent/JP2025090679A/ja active Pending